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ABSTRACT: Tec family nonreceptor tyrosine kinases are key immunological enzymes that control processes
that range from T and B cell development to reorganization of the actin cytoskeleton. The full-length Tec
kinases have been resistant to crystallization. This lack of structural data and the paucity of in Vitro
biochemical data for this kinase family leave a void in our understanding of Tec kinase regulation. In this
report we have used interleukin-2 tyrosine kinase (Itk) as a model system to gain insight into the regulatory
apparatus of the Tec kinases. Use of a quantitative in Vitro kinase assay has uncovered an essential role
for the short linker region flanked by the SH2 and kinase domains of Itk in positively regulating Itk
catalytic activity. The precise residues that allosterically regulate Itk are conserved among Tec kinases,
pointing to the conserved nature of this regulatory mechanism within the family. These findings indicate
that Tec kinases are not regulated in the same manner as the Src kinases but rather share some of the
regulatory features of Csk instead.
Protein kinases have evolved a variety of regulatory
mechanisms that exploit the effects of site-specific phos-
phorylation and precise protein/domain interactions (1, 2).
The largest family of nonreceptor protein tyrosine kinases
consists of the eleven Src kinases (3) that each contain an
N-terminal unique region, followed by an Src homology-3
(SH31) domain, Src homology-2 (SH2) domain, catalytic
domain, and a C-terminal tail with a conserved regulatory
tyrosine. A significant leap in our understanding of kinase
regulation has been provided by the three-dimensional
structures of two Src family kinases (Hck and Src) in their
inactive states (4-6). These structures reveal that the SH3
and SH2 domains are located on the “back” surface of the
kinase domain mediating a network of intramolecular
interactions that stabilize the kinase domain in an inactiVe
conformation.
The C-terminal Src kinase (Csk) shares a similar overall
domain architecture with Src yet lacks the C-terminal tail
that contains the regulatory tyrosine residue of Src (7). The
three-dimensional structure of full-length, active Csk shows
that the regulatory SH3 and SH2 domains are placed on top
of the N-terminal lobe of the kinase domain with the two
linker regions (between SH3 and SH2 and between SH2 and
the kinase domain) running almost parallel to each other and
extensively contacting the N-terminal lobe of the kinase
domain (7). These contacts serve to stabilize the orientation
of the Csk C-helix that is required for full catalytic activity.
An interesting contrast exists between the Csk and Src
kinases in that the noncatalytic SH3 and SH2 domains of
Src serve a negative regulatory role (deletion or mutation of
these domains results in increased activity of the neighboring
kinase domain) while the same noncatalytic domains in Csk
serve a positive regulatory role. Indeed, the isolated Csk
kinase domain exhibits very poor catalytic activity while the
isolated Src kinase domain is fully active (8, 9). Thus, in
two protein tyrosine kinases that appear closely related in
domain structure, the SH3 and SH2 domains play opposite
regulatory roles. These opposing regulatory functions make
simple predictions related to the regulation of other kinase
families quite challenging. One such group of tyrosine
kinases is the Tec family (Tec, Btk, Rlk/Txk, Bmx/Etk, and
Itk), proteins that mediate signals downstream of a variety
of receptors on multiple cell types including B and T cells
(10-12).
The Tec family of nonreceptor tyrosine kinases contains
the ubiquitous SH3 and SH2 domains as well as a pleckstrin
homology (PH) and Tec homology (TH) domain (10).
Activation of Tec kinases involves transphosphorylation of
the activation loop of the kinase domain by Src family
kinases, followed by autophosphorylation within the SH3
domain (11). For Itk, this corresponds to phosphorylation
on Y511 within the activation loop of the kinase domain by
the Src family kinase Lck, followed by autophosphorylation
on Y180 within the SH3 domain (13, 14). In Vitro kinase
assays using immunoprecipitated enzymes have shown that
while phosphorylation on Itk Y511 is critical for Itk activity,
phosphorylation on Itk Y180 is dispensable for Itk catalytic
activity (14). While high-resolution structures of the isolated
domains derived from many of the Tec kinases have been
solved (15-19), the current lack of structural information
for the full-length kinases or even multidomain fragments
of the Tec kinases creates a void in our understanding of
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their regulation. Biochemical analyses probing the regulatory
mechanisms at work within the Tec family kinases have been
limited to in ViVo experiments and in Vitro assays using
immunoprecipitated proteins (20-24). These experiments
have identified the in ViVo requirements for the different
domains of the Tec kinase, yet it has been difficult to
delineate the contribution of specific amino acids to intrinsic
activity. In Vitro activity measurements using immunopre-
cipitated enzymes are difficult to quantify accurately and only
detect changes in overall activity, without distinguishing
between effects on substrate affinity versus catalytic turnover.
In this report we have examined Itk as a model system to
understand the regulation of Tec family kinases by the use
of quantitative kinetic analysis. This approach allows a direct
measure of the extent to which specific amino acid mutations
or domain deletions affect both substrate affinity (Km) and
catalytic activity (kcat). We have identified the 17-residue
linker sequence between the SH2 and kinase domains (the
SH2-kinase linker) as a critical component that maintains
Itk kinase activity (kcat/Km). Furthermore, we identify several
specific residues that mediate interactions between this
regulatory region and the catalytic domain of Itk and extend
these observations to other Tec family members highlighting
the conserved nature of the regulation. Taken together with
the insights provided by structures of other tyrosine kinases,
our results provide a framework to understand the regulation
of the Tec kinases at the molecular level.
EXPERIMENTAL PROCEDURES
BaculoViral and Bacterial Constructs. Full-length and
N-terminal deletion mutants of wild-type (WT) and kinase
dead (K390R) Itk (mouse sequence) were PCR amplified
using a reverse primer which encoded a FLAG epitope tag.
The PCR products were cloned into the pENTR/D-TOPO
vector (Invitrogen) by TOPO cloning. Full-length Btk and
full-length Tec IV were PCR amplified and cloned into the
same vector. Point mutations in the full-length constructs
were created by using the site-directed mutagenesis (SDM)
kit (Stratagene). The bacterial expression construct for the
Itk SH3-SH2 fragment has been described previously (25).
All constructs were verified by sequencing at the Iowa State
Univeristy DNA synthesis and sequencing facility.
BaculoVirus Production. The pENTR vectors with various
inserts were recombined in Vitro with BaculoDirect C-Term
Linear DNA using the LR Clonase II enzyme (Invitrogen).
The DNA was transfected into Sf9 cells using Effectene
(Qiagen) followed by three rounds of viral selection and
amplification. For protein production, the cells were infected
with a 1:1 ratio of Itk:Lck baculovirus. A 1:1 ratio of Itk:
Lck baculovirus was chosen as it achieved maximal phos-
phorylation on Itk Y511 (data not shown). The cells were
harvested 72 h postinfection and stored at -80 °C.
Protein Purification. Bacterial protein purification of Itk
SH3SH2 domain was carried out as described previously
(25). All other proteins used in this report were purified from
Sf9 cells. Protein purification from Sf9 cells was carried as
previously described with minor modifications (26). Briefly,
the cell pellets were resuspended in lysis buffer (50 mM Tris
pH 8.0, 500 mM NaCl, 2 mM EDTA, 1 mM PMSF) and
lysed by dounce homogenization. The homogenate was spun
at 16K for 1 h at 4 °C. Glycerol was added to the supernatant
to a final volume of 10%, and then incubated with anti-FLAG
M2 affinity resin (Sigma) at 4 °C. The resin was rinsed in
wash buffer (50 mM Tris pH 8.0, 500 mM NaCl, 1 mM
PMSF, 10% glycerol), and the protein was eluted in elution
buffer (wash buffer with 200 íg/mL FLAG peptide). The
purified protein was quantified by measuring absorbance at
280 nm. All proteins were greater than 95% pure by
Coomassie staining. Purified proteins were monitored for
phosphorylation on Itk Y511 by Western blotting using a
Btk pY551 specific antibody. Phosphorylation on Itk Y180
was monitored using a Btk pY223 specific antibody (14).
All Western blots were developed by chemiluminescence
followed by autoradiography. The ratio of intensities of the
phosphorylated (pY511) band to that of the total protein
(from the anti-FLAG blot) was used to compare the phos-
phorylation levels of the various proteins.
Kinase Assay. Following procedures outlined previously
(26), Km determinations for ATP or Peptide B [(aminohex-
anoyl biotin-EQEDEPEGIYGVLF-NH2) (Anaspec Inc.)]
were carried out by incubating purified enzyme in reaction
buffer (50 mM Hepes pH 7.0, 10 mM MgCl2, 1 mM DTT,
1 mg/mL BSA, and 1 mM Pefabloc) and 5 íCi of [32P] ATP
(Amersham Biosciences) at room temperature. Peptide B
concentration was varied between 0 and 400 íM. ATP
concentration was varied between 0 and 320 íM. The
enzyme concentrations used for comparison ranged from 50
nM to 2 íM. Each assay was done in duplicate. Data was
fit with the Michaelis-Menten equation using GraphFit 5
software.
In ViVo Kinase Assay and Western Blotting. Sf9 cells were
infected with the respective Itk virus. Three days postinfec-
tion, the cells were lysed in radioimmunoprecipitation
(RIPA) buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1% NP-40, 1 mM NaF, 1 mM DTT, 1 mM PMSF).
The lysate was spun at 10000g for 10 min at 4 °C. The
supernatants were normalized for protein content using the
Bradford assay, separated by SDS-PAGE, and transferred
onto a PVDF membrane. The membranes were then blotted
with either an anti-phosphotyrosine antibody (4G10 from
Upstate) or anti-FLAG antibody (Sigma).
RESULTS
The SH2-Kinase Linker Region Is Critical for Itk ActiVity.
It has been noted previously that the isolated kinase domain
of Itk exhibits poor catalytic activity when compared to the
full-length enzyme (17, 26). This finding implies a positive
regulatory role for the noncatalytic domains adjacent to the
Itk kinase domain. To determine the precise contribution of
each regulatory domain to the kinase activity of Itk, we
compared the in Vitro activities of a series of N-terminal
deletion constructs (Figure 1A). Kinase assays were carried
out using peptide B (EQEDEPEGIYGVLF), which has been
shown to be a substrate for full-length Itk (26). The kinase
inactive (K390R) versions of each deletion construct show
negligible activity when compared to the wild-type (WT)
full-length enzyme, indicating that the measured activity
corresponds to Itk and not to impurities that may copurify
with Itk (Supporting Information Figure 1a). The substrate
curves for WT full-length Itk and the panel of deletion
constructs are shown in Figure 1B,C. The fit of these data
yielded values for kcat and Km for each construct. The ratio
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of kcat/Km was determined for each Itk fragment and
compared to that of the full-length enzyme (Table 1).
Hereafter, kinase activity refers to the ratio of kcat/Km, unless
specified otherwise.
Several features emerge on consideration of the kinetic
data for full-length Itk and related deletions. Most notably,
the only construct that exhibits negligible kinase activity is
the isolated kinase domain (KD). The slightly larger fragment
that contains the 17-residue SH2-kinase linker sequence plus
the kinase domain (LKD) retains nearly half of the activity
of the full-length enzyme (Figure 1, Table 1); this is in spite
of the fact that the overall level of phosphorylation on Y511
(a parameter previously linked to Itk activity (13)) is
significantly lower for LKD than full-length enzyme (Figure
1D; lanes 1 and 4)). However, Y511 phosphorylation levels
are identical between KD and LKD, as are the Km values
for peptide B and ATP, which are, within error, unchanged
from that of full-length Itk. Thus, the short 17 amino acid
region located just N-terminal to the Itk kinase domain
appears to significantly stabilize the active conformation of
the Itk kinase domain as evidenced by an increase in kcat for
LKD compared to that of KD. The difference in the catalytic
properties of LKD and KD can also be observed in the
phosphorylation levels of a protein substrate (Figure 1E).
Using the Itk SH3-SH2 fragment that contains the auto-
phosphorylation site of Itk (Y180 in the SH3 domain) as a
substrate (14), it is apparent that the Itk LKD fragment
exhibits greater activity when compared to the isolated Itk
KD. This qualitative assessment of activities is consistent
with the kinetic parameters that suggest a role for the 17
residue linker in increasing the kinase activity of Itk.
Next we examined the kinetic parameters corresponding
to the larger Itk fragments that include the SH2 domain
(2KD) and the SH3-SH2 region (32KD). These two
fragments are active and show similar kinetic behavior to
one another, suggesting that the SH3 domain is dispensable
for this level of Itk kinase activity (Figure 1B,C, Table 1).
The Km values for peptide B binding to the 2KD and 32KD
fragments indicate a 6- to 8-fold drop in substrate affinity
(increased Km) when compared to full-length enzyme. The
Km values measured for ATP binding to the 32KD and 2KD
constructs are significantly closer to full-length enzyme. The
peptide B binding data therefore suggest that in the context
of the full-length enzyme, the PH-TH region of Itk may
play a role in sequestering the SH2 region in a manner that
facilitates substrate binding to the active site. As indicated
above, further removal of the SH2 domain (LKD and KD)
restores affinity for the substrates to near wild-type levels
(Table 1).
Despite the increase in Km values observed for 2KD and
32KD, the overall activity (kcat/Km) of these fragments drops
less than 2-fold compared to full-length enzyme. This is
explained by the concomitant increase in kcat that balances
the decrease in substrate affinity of the 32KD and 2KD
fragments. Specifically, deletion of the PH-TH or PH-TH-
SH3 region of Itk leads to a 4- to 5-fold increase in kcat
(Table 1), indicating that the positive regulatory interactions
between the SH2 domain or the SH2-kinase linker and the
catalytic domain may be enhanced in the absence of the PH-
TH domains. These data suggest that it will be interesting
to explore the precise balance of the regulatory role(s) of
the N-terminal PH-TH domains especially in light of their
established role in membrane association during T cell
FIGURE 1: The SH2-kinase linker of Itk is critical for kinase
activity. (A) Itk deletion fragments. (B and C) The in Vitro kinase
activities of the deletion fragments of Itk were compared. Substrate
(peptide B and ATP) curves of ItkFL (open squares), 32KD (filled
circles), 2KD, (open triangles), LKD (filled triangles), and KD (open
circles) were fit to the Michaelis-Menten equation to obtain the
kinetic parameters reported in Table 1. (D) Western blot showing
the pY511 levels of various FLAG-tagged Itk mutants. Lanes
1-5: Itk FL, 32KD, 2KD, LKD, and KD. (E) Comparison of the
in Vitro kinase activities of LKD with that of KD using a protein
substrate. 2 íM purified FLAG-tagged Itk LKD or Itk KD was
incubated with 1 íM (lanes 2 and 4) or 10 íM (lanes 3 and 5) Itk
SH3SH2 domain in an in Vitro kinase reaction. Lane 1 is 10 íM
Itk SH3SH2 domain alone with no enzyme. The samples were
Western blotted with the Btk anti-pY223 antibody. Coomassie stain
and an anti-FLAG blot show protein levels.
Table 1: Kinetic Parameters of Itk Deletion Constructs and Point
Mutants
enzyme Km(peptideB) íM kcat min-1 kcat/Km min-1 íM-1
ItkFL 46 ( 13 0.54 ( 0.05 0.01
KD 84 ( 19 0.02 ( 0.002 0.0002
LKD 87 ( 19 0.39 ( 0.03 0.004
2KD 290 ( 49 1.94 ( 0.18 0.007
32KD 388 ( 61 2.56 ( 0.20 0.007
W355A 115 ( 25 0.02 ( 0.001 0.0002
M410A 43 ( 4.1 0.05 ( 0.001 0.001
Y421A 51 ( 6.7 0.25 ( 0.01 0.005
Y421F 73 ( 5.0 0.74 ( 0.02 0.01
L350A 55 ( 11 0.40 ( 0.03 0.007
E394A 54 ( 5.8 0.27 ( 0.01 0.005
enzyme Km(ATP) íM kcat min-1 kcat/Km min-1 íM-1
ItkFL 107 ( 35 0.43 ( 0.05 0.004
KD 45 ( 27 0.003 ( 0.001 0.0001
LKD 169 ( 28 0.18 ( 0.01 0.001
2KD 297 ( 56 1.13 ( 0.13 0.004
32KD 194 ( 66 0.35 ( 0.06 0.002
W355A 93 ( 17 0.01 ( 0.001 0.0001
M410A 166 ( 31 0.02 ( 0.002 0.0001
Y421A 155 ( 42 0.32 ( 0.04 0.002
Y421F 132 ( 33 0.56 ( 0.07 0.004
L350A 189 ( 25 0.69 ( 0.05 0.004
E394A 136 ( 45 0.26 ( 0.04 0.002
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signaling (27, 28). Moreover, Y511 phosphorylation levels
for 32KD and 2KD appear slightly higher than that of full-
length Itk, and this difference could also account for the
increase in kcat values for the 32KD and 2KD fragments.
Indeed, the differences in Y511 phosphorylation levels across
the panel of deletion mutants suggest that more targeted point
mutants might provide clearer insights into the regulatory
role of the noncatalytic region of Itk.
W355 in the SH2-Kinase Linker Region Is Critical for
the ActiVity of Tec Family Kinases. The large difference in
kcat between the LKD and KD fragments, combined with
similar Km values and identical levels of Y511 phosphory-
lation for LKD and KD, clearly suggests that the 17 amino
acid linker is a critical component of the Itk regulatory
apparatus that merits further exploration. Sequence alignment
of the SH2-kinase linker region of Tec family kinases with
those of Src and Csk shows the presence of a conserved Trp
(Figure 2A). This conserved Trp mediates key regulatory
interactions between the noncatalytic and catalytic domains
of both the Src and Csk kinases (29, 30) and in turn exerts
opposing effects on the catalytic activity of Src and Csk.
Specifically, mutation of this Trp to Ala in the Src family
kinase Hck (W260A) activates Hck, whereas the analogous
mutation in Csk (W188A) leads to inactivation of Csk.
To determine the extent to which this residue plays a
regulatory role in Itk, W355 was mutated to Ala within the
full-length protein and the kinetic parameters of the resulting
mutant were measured. Mutation of this single residue in
full-length Itk leads to a precipitous drop in activity to the
level of activity associated with the isolated kinase domain
(Figure 2B, Table 1). The decrease in activity of the W355A
mutant is not due to decreased stability of this protein, as
the urea denaturation curve of the Itk W355A mutant is
indistinguishable from that of the WT protein (Supporting
Information Figure 1b). Since the Km for peptide B and ATP
for the W355A mutant is similar to that of the WT enzyme,
the drop in kcat/Km is not due to changes in the ability of the
kinase domain to interact with the substrate, but rather to a
complete loss of positive regulation by the noncatalytic
domains. This finding extends to other Tec family members,
as mutation of the corresponding Trp in both Btk (W395A)
and Tec (W362A) also shows a sharp decrease in kinase
activity (Figure 2C). Indeed, this observation is interesting
in light of a recent report that assessed the effect of disease
causing mutations in Btk that included the W395 mutation
(31). Immunoprecipitated Btk W395A mutant exhibited very
poor activity in Vitro and in ViVo. Thus, this Trp is a critical
residue within the regulatory apparatus of the Tec family
kinases.
Probing the Role of Specific Amino Acids in Maintaining
Itk ActiVity. In contrast to the abundant structural data on
full-length Src and Csk family kinases, there is currently no
structural information available for any of the full-length Tec
kinases, thwarting efforts aimed at gaining molecular level
insight into Tec kinase regulation. Given the positive
regulatory role played by the noncatalytic domains of both
FIGURE 2: The conserved Trp in the SH2-kinase linker regulates the activity of Tec family kinases. (A) Sequence alignment of Tec family
kinases with Src and Csk. The region depicted begins at the C-terminus of the SH2 domain and extends beyond the C-helix of the N-terminal
lobe of the kinase domain. The SH2-kinase linker and the C-helix regions are indicated above the sequences. The conserved Trp in the
SH2-kinase linker and the Met residue that is conserved among the Tec kinases are boxed. Asterisks indicate the amino acid residues that
are evaluated in this work. (B) In Vitro kinase activity of full-length wild-type Itk (open squares) and the W355A (filled circles) mutant of
Itk using peptide B as a substrate. (C) Comparison of wild-type full-length activity of Btk, Tec, and Itk to the corresponding Trp mutants
of Btk, Tec, and Itk. All data shown are the average of at least two independent experiments.
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Itk and Csk, we overlaid the available crystal structure of
the isolated Itk kinase domain (17) with the structure of full-
length Csk (7) in an effort to identify candidate residues
within the SH2-kinase linker stretch and the Itk kinase
domain itself that are likely to be involved in mediating
positive regulatory contacts in Itk (Figure 3A).
Mutations in the ConserVed Trp Pocket Deregulate Itk
ActiVity. As already demonstrated, the conserved Trp located
in the SH2-kinase linker serves an important role in
maintaining Csk (30) and Itk (this work) in their active
conformations. Indeed, structures of the inactive and active
configurations of tyrosine kinases (7, 32-34) can be
characterized by the position of this conserved Trp residue.
In superimposing the structures of two active tyrosine kinases
(Csk and Src) with two inactive tyrosine kinases (Hck and
Src) we find that the bulky Trp side chain either acts as a
wedge that prevents the inward movement of the C-helix in
the inactive state or switches to a conformation that stabilizes
the C-helix in the conformation characteristic of active
kinases (Figure 3B). For example, in the structure of full-
length active Csk, W188 (corresponding to W355 in Itk) lies
parallel to the C-helix rather than in a perpendicular position
that would maintain the C-helix in its inactive conformation
(Figure 3A,B).
Given the correlation between the position of the Trp side
chain and kinase activation (Figure 3B), as well as our
finding that mutation of W355 in Itk is inactivating
(Figure 2), we hypothesize that W355 of Itk adopts a position
similar to that of Csk (Figure 3). The model of the Csk/Itk
superposition therefore allows identification of additional Itk
residues that play a putative role in stabilizing the active
conformation of the C-helix via contacts to W355 in the full-
length kinase. Excluded from our mutational analysis are
amino acids that directly contact ATP in the Itk kinase
domain structure (17) in order to selectively probe allosteric
regulation of Itk by the noncatalytic regions. With these
criteria in mind, three residues comprising a hydrophobic
patch can be readily identified that likely surround the
conserved W355 in Itk (Figure 3A, inset). Two of the side
chains, M410 and Y421, are present in the fragment of Itk
that has been crystallized while the third, L350, resides in
the SH2-kinase linker region and is not part of the published
Itk structure. This latter residue corresponds to F183 in Csk
and to L255 in Src. Mutation of L255 in Src or F183 in Csk
has been previously implicated in regulation of these kinases,
providing further support for an important role for this
position in Itk (35-37).
As anticipated, the Km values for ATP binding to each Itk
point mutant are unchanged from wild-type full-length
enzyme (Table 1). Inspection of Y511 phosphorylation for
each point mutant (including the already discussed W355
site) reveals levels that are significantly more uniform than
those observed for the deletion constructs (Figure 4A). With
the exception of L350 (discussed below) the variation in
Y511 phosphorylation among the point mutants reflects, at
most, a 2-fold decrease for the W355A mutant when
compared to the WT enzyme, much less than the greater
than 10-fold decrease in Y511 phosphorylation observed
earlier for LKD when compared to WT protein. Since the
LKD fragment is about 40% as active as the WT enzyme,
the 2-fold difference in Y511 phosphorylation of the W355A
mutant cannot solely account for the greater than 90% drop
in activity of this mutant. Thus, the differences in the
measured catalytic activities of the full-length mutants can
be interpreted in terms of the regulatory roles played by the
amino acid sites in question.
M410 in Itk C-Helix Is Critical for ActiVity. Within the
putative active form of full-length Itk, the location of M410
in the C-helix of Itk seems well positioned to stabilize W355
in a configuration that is parallel to the C-helix and may
therefore be a critical residue in the Itk regulatory apparatus
(Figure 3A). Indeed, sequence alignment of Itk from different
organisms shows that this Met is conserved throughout
evolution. Moreover, this residue is unique to the Tec family
kinases where it is also conserved (Figure 2A). Mutation of
this Met to Ala in full-length Itk leads to a significant drop
in activity, with no change in Km for either the peptide B
substrate or ATP (Figure 4B,C, Table 1). The decrease in
activity of the M410A mutant is also not due to decreased
stability of this protein, as the urea denaturation curve of
FIGURE 3: Comparison of kinase domain structures. (A) Superposition of the structure of the Itk kinase domain (1SM2, blue) with the
structure of full-length Csk (1K9A, salmon). The SH3 domain of Csk is not included in the superposition. The boxed region is enlarged to
show the residues mutated in this study. The SH2-kinase linker of Csk is in red. The side chains of E394, M410, and Y421 of Itk are
depicted in blue. The Csk residues W188 (corresponds to Itk W355) and F183 (corresponds to Itk L350) are in red. (B) Overlay of the
structures of inactive Src (2PTK, red), inactive Hck (1QCF, salmon), active Src (1Y57, dark blue), and active Csk (1K9A, light blue). The
region shown is the C-helix and the conserved Trp. Conversion from the inactive to the active state in Src kinase is accompanied by
movement in the C-helix and the conserved Trp. Structural superpositions were generated using the alignment program within PyMOL
(41). The entire sequence of each kinase domain was used for alignment.
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the Itk M410A mutant is identical to that of the WT protein
(Supporting Information Figure 1b). These data suggest that
Itk M410 is a critical residue within the small kinase lobe
that likely stabilizes positive regulatory interactions to the
SH2-kinase linker via W355.
Probing the Regulatory Role of L350 and Y421. Further
perturbations to the hypothetical hydrophobic pocket sur-
rounding W355 in Itk (Figure 3A) involved mutation of Y421
to Ala, Asp, or Phe and L350 to Ala. The Itk Y421A mutant
maintains approximately half of the activity of wild-type
enzyme while mutation of this same residue to phenylalanine
Y421F had no effect on activity (Figure 4B,C, Table 1).
Introduction of a negative charge into this pocket by mutating
Y421 to Asp leads to a complete loss of activity (Supporting
Information Figure 1a). The Itk L350A mutant retains three-
quarters of the activity of the wild-type enzyme (Figure 4B,C,
Table 1). The identical position in both Src and Csk has been
extensively mutated. For Src, mutation at this site (L255A)
increases kinase activity several fold, consistent with the
structure of Src showing a critical role for L255 in stabilizing
the inactive conformation (35). Mutation of the corresponding
position in Csk (F183) leads to a decrease in kinase activity
(36, 37). It should be noted that, unlike the other Itk point
mutants in this study, the Y511 phosphorylation level of the
L350A mutant differs significantly from that of wild-type
full-length Itk. Specifically, the data in Figure 4A lanes 1
and 2 indicate that a larger fraction of the total Itk L350A
enzyme is phosphorylated on Y511 when compared to wild-
type enzyme, a result that suggests that the measured catalytic
activity of the L350A mutant (Table 1) is probably artificially
high. Thus, the actual decrease in catalytic efficiency for the
Itk L350A mutant could be even more pronounced than
indicated by our measured kinetic parameters and further
suggests that the active conformation of Itk in this region
more closely resembles that of Csk. Together with the loss
of activity upon mutation of Y421 and M410, these findings
highlight the importance of the putative hydrophobic pocket
surrounding W355 in Itk.
E394 in the N-Terminal Kinase Lobe Regulates ActiVity.
Results of our deletion study provide evidence that the SH2
domain of Itk contributes to the intrinsic kinase activity of
Itk (Figure 1). This is interesting in light of previous work
pointing to the importance of the SH2 domain in T cell
activation (22). Moreover, structural work suggests that
phospholigand binding to the Itk SH2 domain induces
structural changes on the distal surface of the SH2 domain,
including a part of the B-helix, the âE and âF strands (38).
In the full-length Csk structure it is these precise secondary
structural elements of the SH2 domain that are in close
proximity to the small lobe of the Csk kinase domain (7).
The crystal structure of Csk shows that N226 in the â3
C-helix loop of the N-terminal lobe of the kinase domain is
in close proximity to the SH2 domain of Csk (7) and
mutation of this residue to Ala results in a 50% decrease in
Csk activity (36). Structural alignment of the isolated Itk
kinase domain with full-length Csk brings Itk E394 within
the â3 C-helix loop in close proximity to the Csk SH2
domain (Figure 3A). Moreover, SAXS analysis of full-length
Btk shows that the SH2 domain is adjacent to the N-terminal
lobe of the kinase domain (39). To determine if this residue
is in fact involved in regulating Itk activity, we measured
the kinetic parameters for the Itk E394A mutant. Mutation
of E394 to Ala leads to a decrease in Itk activity to less
than half that of the full-length wild-type enzyme
(Figure 4B,C, Table 1). Again, the Km values for both peptide
B and ATP remain unchanged, showing that substrate
recognition is not affected by this mutation (Table 1). These
data suggest that E394 is important for positively modulating
Itk activity, and may be in direct contact with the SH2
domain in the active conformation of this enzyme.
In ViVo ActiVity of Itk Full-Length Mutants. The in Vitro
kinetic analyses of the Itk mutants described above revealed
varying effects on activity and allowed precise measurement
of Km and kcat. To examine the extent to which these kinetic
parameters reflect the behavior of each mutant in ViVo, we
infected Sf9 cells with the panel of Itk baculoviruses, and
tested overall phosphotyrosine levels within the cell by
Western blotting with a phosphotyrosine specific antibody
(Figure 4D). ItkFL, L350A, and Y421F mutants all showed
intense tyrosine phosphorylation, consistent with the in Vitro
kinase data indicating that these mutations do not adversely
affect kinase activity. The other Itk mutants, W355A, E394A,
M410A, Y421A as well as the kinase inactive Itk mutant
(K390R) all showed low overall phosphorylation levels,
consistent with their poor activity in Vitro.
DISCUSSION
Orchestrated changes in phosphorylation status and/or
domain interactions regulate enzyme activity during cell
signaling. Using Itk as a model system for the Tec kinases,
we have uncovered the positive role played by the SH2-
kinase linker in maintaining the catalytic activity of Itk.
Moreover, extension of the construct to include the SH2
FIGURE 4: Mutations around the conserved Trp in Itk influence
kinase activity. (A) Western blot showing the pY511 levels of
various FLAG-tagged Itk mutants. Lanes 1-6: Itk FL, L350A,
W355A, E395A, M410A, and Y421A. (B and C) Substrate (peptide
B and ATP) curves of the Itk full-length point mutants: L350A
(open squares), E394A (filled circles), M410A (filled squares),
Y421A (open triangles), Y421F (filled triangles), and W355A (open
circles). For reference the Y421F mutant (filled triangles) exhibits
activity that is nearly identical to that of full-length wild-type Itk.
Kinetic parameters for the mutants are reported in Table 1. (D) In
ViVo activity of Itk full-length mutants correlates with in Vitro kinase
activity. Sf9 cells were infected with baculoviruses for the full-
length FLAG-tagged Itk mutants. The cell lysates were then probed
by Western blotting with an anti-pTyr or anti-FLAG antibody to
detect total Itk levels. Lanes 1-9: uninfected cells, WT, kinase
dead (K390R), L350A, W355A, E394A, M410A, Y421A, and
Y421F. Data shown are representative of two independent experi-
ments.
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domain leads to further enhancement of Itk activity. While
this could be due in part to higher levels of Y511 phospho-
rylation for this Itk fragment, it is also likely that the presence
of the SH2 domain serves to stabilize the proper orientation
of the 17 amino acid linker region. This is consistent with
the results of mutating E394, putatively a site of contact
between the kinase lobe and the SH2 domain, and previous
in ViVo data showing that deletion of the SH2 domain from
full-length Itk leads to decreased levels of Itk phosphorylation
(22). Thus, our in Vitro kinase assay shows that, in addition
to playing a role in mediating protein-protein interactions
in ViVo, the Itk SH2 domain may also play a key role in
maintaining the active conformation of Itk.
Based on the mutational analysis of Itk presented here, it
is tempting to predict an arrangement for the active state of
the Tec family kinases that is similar to that of Csk. We
have reported significant similarities in the behavior of Itk
and Csk, yet some details of the Itk and Csk regulatory
apparatus seem distinct. For example, both the SH3 and SH2
domains positively modulate Csk activity (8), while our
results indicate that Itk requires the 17 amino acid linker
preceding the kinase domain to regain much of the catalytic
activity that is lost on deletion of the entire regulatory region
and only the SH2 domain and not the entire SH3-SH2 unit
appears to further stabilize the active conformation of the
kinase. The activity of the isolated kinase domain of Csk
can be enhanced by the addition of the SH3 or SH3-SH2
domains in trans (40). In contrast, we found that addition of
neither the Itk SH2 domain, the SH2-linker portion, nor the
SH3-SH2 fragment in trans to the isolated kinase domain
had any measurable effect on the in Vitro activity of the Itk
kinase domain (data not shown). Previous in ViVo work
showed that an Itk SH2 domain (R265K) mutant that lacks
the ability to bind phospholigand exhibits poor activity (22).
However, our efforts to directly test the effect of phospho-
peptide binding to the SH2 domain on the catalytic activity
of Itk were thwarted due to the low affinity and toxicity
effects of the phosphopeptide on in Vitro kinase activity (data
not shown). Finally, it is also notable that SAXS analysis of
full-length Btk predicts a linear arrangement for the regula-
tory domains that, if representative of the active conforma-
tion, would be inconsistent with a Csk-like arrangement (39).
Thus, the non-receptor tyrosine kinases that share the SH3-
SH2-kinase domain cassette (i.e., Src, Csk, Abl, and Itk)
are distinguished by variations in their regulatory mecha-
nisms. Ultimately, the regulatory differences that are becom-
ing evident among these apparently closely related tyrosine
kinases could be exploited to develop reagents that selectively
alter the activity of one enzyme over others. The appropriate
targets of such reagents may in fact be the noncatalytic
regulatory domains instead of the active sites of each of these
kinases.
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The kinase activities of Itk full-length Y421D mutant and
various catalytically inactive (K390R) deletion fragments
were compared with that of the wild-type (WT) enzyme. The
stability of Itk full-length W355A and M410A mutants was
compared to that of the WT enzyme using urea denaturation
curves. This material is available free of charge via the
Internet at http://pubs.acs.org.
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